Cargando…
In Vitro Evaluation of Farnesyltransferase Inhibitor and its Effect in Combination with 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor against Naegleria fowleri
Free-living amoeba Naegleria fowleri causes a rapidly fatal infection primary amebic meningoencephalitis (PAM) in children. The drug of choice in treating PAM is amphotericin B, but very few patients treated with amphotericin B have survived PAM. Therefore, development of efficient drugs is a critic...
Autores principales: | Hahn, Hye Jee, Debnath, Anjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560193/ https://www.ncbi.nlm.nih.gov/pubmed/32842691 http://dx.doi.org/10.3390/pathogens9090689 |
Ejemplares similares
-
Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors
por: Roy, Satyajeet, et al.
Publicado: (2017) -
The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in renal disease
por: Gomez, Sabas I, et al.
Publicado: (2014) -
In silico investigation on alkaloids of Rauwolfia serpentina as potential inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA reductase
por: Azmi, Muhammad Bilal, et al.
Publicado: (2021) -
Enzymatic chokepoints and synergistic drug targets in the sterol biosynthesis pathway of Naegleria fowleri
por: Zhou, Wenxu, et al.
Publicado: (2018) -
Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies
por: Drouot, Laurent, et al.
Publicado: (2014)